OSR Health, Inc. (OSRH) Form 8-K — Oct 28, 2026
$OSRHForm 8-KItems 3.01, 7.01, 9.01Filed Oct 28, 2026, 9:30 AM ET0001213900-26-113126Original filing
OSR Health received a written decision from the Nasdaq Hearings Panel on October 23, 2026, denying continued listing and determining to delist the company's securities for non-compliance with the $1.00 minimum bid price requirement. Trading on Nasdaq was suspended August 26, 2026, and shares now quote over-the-counter under OSRH and OSRHW. The company notably chose not to pursue a reverse stock split during the compliance process and says it is evaluating strategic and corporate alternatives, with a further update promised by November 6, 2026.
Key figures
- Funding mechanism
- $15 million equity put option against BCM Europe AG
- Panel decision date
- 2026-10-23
- Next update deadline
- 2026-11-06
- Nasdaq suspension date
- 2026-08-26
- Warrant exercise price
- $11.50
- Minimum bid price requirement
- $1.00
- Convertible note conversion price range
- $2.00 to $5.00 per share
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.